-+ 0.00%
-+ 0.00%
-+ 0.00%

CONDUIT PHARMACEUTICALS COMPLETES STRATEGIC REVIEW WITH SARBORG TO MAP REVOLUTIONIZING DRUG DEVELOPMENT WITH ARTIFICIAL INTELLIGENCE

Reuters·01/28/2025 10:30:00

Please log in to view news